Christine E. Mona

1.0k total citations
25 papers, 625 citations indexed

About

Christine E. Mona is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christine E. Mona has authored 25 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christine E. Mona's work include Peptidase Inhibition and Analysis (13 papers), Prostate Cancer Treatment and Research (8 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). Christine E. Mona is often cited by papers focused on Peptidase Inhibition and Analysis (13 papers), Prostate Cancer Treatment and Research (8 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). Christine E. Mona collaborates with scholars based in United States, Germany and Canada. Christine E. Mona's co-authors include Jérémie Calais, Johannes Czernin, Roger Slavik, Katharina Lückerath, Catherine Meyer, Magnus Dahlbom, Caius G. Radu, Sébastien Vauclin, Uwe Haberkorn and Thomas Lindner and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Christine E. Mona

23 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christine E. Mona United States 12 443 257 213 189 171 25 625
Euy Sung Moon Germany 16 736 1.7× 380 1.5× 230 1.1× 66 0.3× 383 2.2× 37 871
Luis David Jiménez‐Franco Germany 9 256 0.6× 219 0.9× 97 0.5× 121 0.6× 113 0.7× 13 420
Ganghua Tang China 10 242 0.5× 166 0.6× 120 0.6× 42 0.2× 134 0.8× 30 404
Katharina Lueckerath Germany 8 325 0.7× 118 0.5× 149 0.7× 58 0.3× 145 0.8× 15 383
Maythinee Chantadisai Thailand 9 229 0.5× 205 0.8× 64 0.3× 92 0.5× 102 0.6× 20 391
Yvonne H. W. Derks Netherlands 11 170 0.4× 197 0.8× 54 0.3× 213 1.1× 54 0.3× 16 479
Gwendolyn Vliegen Belgium 11 277 0.6× 39 0.2× 96 0.5× 58 0.3× 118 0.7× 14 433
Bastiaan M. Privé Netherlands 12 155 0.3× 355 1.4× 67 0.3× 348 1.8× 60 0.4× 27 547
Horacio Amaral Chile 10 157 0.4× 279 1.1× 42 0.2× 315 1.7× 88 0.5× 27 516

Countries citing papers authored by Christine E. Mona

Since Specialization
Citations

This map shows the geographic impact of Christine E. Mona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine E. Mona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine E. Mona more than expected).

Fields of papers citing papers by Christine E. Mona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine E. Mona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine E. Mona. The network helps show where Christine E. Mona may publish in the future.

Co-authorship network of co-authors of Christine E. Mona

This figure shows the co-authorship network connecting the top 25 collaborators of Christine E. Mona. A scholar is included among the top collaborators of Christine E. Mona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine E. Mona. Christine E. Mona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holzgreve, Adrien, Christine E. Mona, Xinmin Li, et al.. (2025). Liquid Biopsy of Circulating Tumor Cells and DNA in the Context of PSMA Radiopharmaceutical Therapy. Journal of Nuclear Medicine. 67(1). 12–14.
2.
Czernin, Johannes, et al.. (2025). Hematological toxicity of [225Ac]Ac-PSMA-617 and [177Lu]Lu-PSMA-617 in RM1-PGLS syngeneic mouse model. EJNMMI Radiopharmacy and Chemistry. 10(1). 12–12. 2 indexed citations
3.
Brouillette, Rebecca L., Christine E. Mona, Firoza Z Lussier, et al.. (2025). A lipidated peptide derived from the C-terminal tail of the vasopressin 2 receptor shows promise as a new β-arrestin inhibitor. SPIRE - Sciences Po Institutional REpository. 212. 107597–107597. 1 indexed citations
4.
Mona, Christine E., et al.. (2024). Preclinical evaluation of 225Ac-labeled minigastrin analog DOTA-CCK-66 for Targeted Alpha Therapy. European Journal of Nuclear Medicine and Molecular Imaging. 52(2). 458–468. 2 indexed citations
5.
Huang, Rong, Chunlai Zuo, Christine E. Mona, et al.. (2024). FAP and PSMA Expression by Immunohistochemistry and PET Imaging in Castration-Resistant Prostate Cancer: A Translational Pilot Study. Journal of Nuclear Medicine. 65(12). jnumed.124.268037–jnumed.124.268037. 3 indexed citations
6.
Brouillette, Rebecca L., Christine E. Mona, Sakeen W. Kashem, et al.. (2024). Discovery of a CCR2-targeting pepducin therapy for chronic pain. Pharmacological Research. 205. 107242–107242. 3 indexed citations
7.
Rosser, Ethan W., Dörthe Schaue, Élie Besserer‐Offroy, et al.. (2024). Evaluating [225Ac]Ac-FAPI-46 for the treatment of soft-tissue sarcoma in mice. European Journal of Nuclear Medicine and Molecular Imaging. 51(13). 4026–4037. 6 indexed citations
8.
Crane, Jacquelyn, Christine E. Mona, Scott D. Nelson, et al.. (2023). Fibroblast Activation Protein Expression in Sarcomas. Sarcoma. 2023. 1–11. 16 indexed citations
9.
Lückerath, Katharina, et al.. (2023). Fibroblast Activation Protein Inhibitor Theranostics. PET Clinics. 18(3). 409–418. 2 indexed citations
10.
Fanelli, Roberto, Élie Besserer‐Offroy, Christine E. Mona, et al.. (2021). Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia. Behavioural Brain Research. 405. 113189–113189. 10 indexed citations
11.
Mona, Christine E., Matthias Benz, Tristan Grogan, et al.. (2021). Correlation of 68Ga-FAPi-46 PET Biodistribution with FAP Expression by Immunohistochemistry in Patients with Solid Cancers: Interim Analysis of a Prospective Translational Exploratory Study. Journal of Nuclear Medicine. 63(7). 1021–1026. 96 indexed citations
12.
Stuparu, Andreea D., Catherine Meyer, Susan Evans‐Axelsson, et al.. (2020). Targeted alpha therapy in a systemic mouse model of prostate cancer - a feasibility study. Theranostics. 10(6). 2612–2620. 19 indexed citations
13.
Stuparu, Andreea D., Joseph Capri, Catherine Meyer, et al.. (2020). Mechanisms of Resistance to Prostate-Specific Membrane Antigen–Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer. Journal of Nuclear Medicine. 62(7). 989–995. 36 indexed citations
14.
Czernin, Johannes, et al.. (2020). Immune-Checkpoint Blockade Enhances225Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer. Journal of Nuclear Medicine. 62(2). 228–231. 70 indexed citations
15.
Sonni, Ida, Stephanie Lee‐Felker, Sanaz Memarzadeh, et al.. (2020). 68Ga-FAPi-46 diffuse bilateral breast uptake in a patient with cervical cancer after hormonal stimulation. European Journal of Nuclear Medicine and Molecular Imaging. 48(3). 924–926. 19 indexed citations
16.
Brouillette, Rebecca L., Élie Besserer‐Offroy, Christine E. Mona, et al.. (2020). Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve pain. Pharmacological Research. 155. 104750–104750. 13 indexed citations
17.
Meyer, Catherine, Magnus Dahlbom, Thomas Lindner, et al.. (2019). Radiation Dosimetry and Biodistribution of 68Ga-FAPI-46 PET Imaging in Cancer Patients. Journal of Nuclear Medicine. 61(8). 1171–1177. 163 indexed citations
18.
Lückerath, Katharina, Andreea D. Stuparu, Wei Liu, et al.. (2018). Detection Threshold and Reproducibility of 68Ga-PSMA11 PET/CT in a Mouse Model of Prostate Cancer. Journal of Nuclear Medicine. 59(9). 1392–1397. 21 indexed citations
19.
Lückerath, Katharina, Wei Liu, Wolfgang P. Fendler, et al.. (2018). Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer. EJNMMI Research. 8(1). 96–96. 64 indexed citations
20.
Mona, Christine E., Élie Besserer‐Offroy, Philip E. Boulais, et al.. (2016). Structure–Activity Relationship and Signaling of New Chimeric CXCR4 Agonists. Journal of Medicinal Chemistry. 59(16). 7512–7524. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Euy Sung Moon Breakdown of academic impact, for papers by Luis David Jiménez‐Franco Breakdown of academic impact, for papers by Ganghua Tang Breakdown of academic impact, for papers by Katharina Lueckerath Breakdown of academic impact, for papers by Maythinee Chantadisai Breakdown of academic impact, for papers by Yvonne H. W. Derks Breakdown of academic impact, for papers by Gwendolyn Vliegen Breakdown of academic impact, for papers by Bastiaan M. Privé Breakdown of academic impact, for papers by Horacio Amaral
Rankless by CCL
2026